BitFrontier Capital Holdings, Inc. (OTCID: BFCH), doing business as UNLOCKD Inc., announced the successful closing of its acquisition of VerdaGenix, LLC, owner and operator of the Ancient Extracts USA wellness platform. The acquisition, finalized pursuant to definitive transaction documents, makes Ancient Extracts USA a wholly owned subsidiary of BFCH, adding an established operating platform with direct-to-consumer infrastructure, commercial operations, proprietary formulations, intellectual property, supplier relationships, inventory, fulfillment capabilities, digital marketing systems, customer acquisition infrastructure, and a diversified catalog of over 20 wellness SKUs already commercialized and in market.
Management views this acquisition as a defining milestone in the Company's evolution into a scalable operating platform focused on wellness, performance, functional products, and human optimization. This transaction follows a series of strategic developments over the past year, including the elimination of more than $2 million in legacy convertible debt, strengthening of the balance sheet and governance infrastructure, restoration of disclosure compliance, acquisition of the EVERMIND intellectual property platform, and expansion of executive leadership.
The Company is now actively transitioning Ancient Extracts into a broader commercialization and expansion phase, focusing on scaling both direct-to-consumer operations and retail distribution opportunities. BFCH confirmed that it is advancing strategic growth capital initiatives to support inventory expansion, operational scaling, customer acquisition, retail channel development, and broader commercialization execution as the platform expands.
Management believes the completion of the acquisition significantly de-risks the Company's broader operating strategy by establishing an active commercial foundation. With operating infrastructure, products, customer acquisition systems, and commercialization capabilities already in place, the Company's focus is shifting toward securing and deploying strategic growth capital to fuel expanded distribution, customer acquisition, inventory scaling, retail penetration, operational infrastructure, and broader long-term platform expansion initiatives.
John P. Gorst, CEO of BFCH, stated: "We are not attempting to create a concept from scratch. Ancient Extracts already has operating infrastructure, commercialized products, existing customers, active distribution channels, and a brand foundation capable of meaningful expansion. Our focus now is execution, commercialization scale, and building a significantly larger operating platform around assets we believe possess real long-term value."
Jordan P. Balencic, D.O., Chairman and Chief Science Officer, added: "Closing Ancient Extracts represents a transformational milestone for BFCH and UNLOCKD. We believe we are still in the early stages of building what can become a much larger operating platform centered around wellness, performance, functional products, cognitive health, and human optimization. Our focus now shifts from corporate restructuring and platform assembly toward commercialization, operational execution, strategic expansion, and long-term value creation."
The Company also confirmed that management continues evaluating additional acquisition opportunities, strategic partnerships, operating assets, and commercialization initiatives aligned with its broader long-term strategy. Separately, BFCH recently received a formal legal opinion concluding that it is not a shell company under Rule 405 of the Securities Act of 1933 based on its operating strategy, asset base, acquisitions, and ongoing activities.
For more information, visit www.UNLOCKDinc.com and view current filings on OTC Markets.
